Indeed, hepatic TLR expression is increased in human NAFLD patients, and in animal models, Tlr2, 4, 5, and Tlr9 have been shown to be associated with the pathogenesis of NAFLD [47–51]. This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatotic liver disease.